The response of hepatocytes isolated from phenobarbitone treated mice to mitogenic growth factors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-05

AUTHORS

Karin Fletcher, Terry C. Orton, J. Kevin Chipman, Alastair J. Strain

ABSTRACT

The ability was investigated of epidermal growth factor (EGF) and hepatocyte growth factor (HGF) to stimulate DNA synthesis in hepatocytes isolated from C57Bl/6J mice following 1, 3, 7, 30 and 90 days pre-treatment with the hepatomegalic drug, phenobarbitone (PB). A 3-fold increase in S-phase labelled hepatocytes was observed in the absence of growth factors after 3 days treatment with PB, which was not seen at other investigated time points. This suggests that the proliferative influence present in vivo at this time interval is maintained in the ex vivo model. Maximum labelling indices of >5-fold the unstimulated control value were observed in hepatocytes isolated from control and 1 day PB pre-treated mice when cultured in the presence of 5 or 10 ng/ml EGF or HGF. Hepatocytes isolated from 3, 7, 30 or 90 day treated mice showed a considerably reduced responsiveness to growth factors; maximum labelling indices did not exceed by a factor of 2 the value obtained in the absence of growth factors. However, the apparent decrease in responsiveness to growth factors in hepatocytes isolated from 3 day pre-treated mice was due to an increased background level of proliferation and the attainment of a `ceiling level' of DNA synthesis at approx. 35%. DNA synthesis was not further enhanced by addition of both EGF and HGF. This maximal level of stimulation may indicate that only a specific hepatocyte sub-population is capable of responding to growth factors under the conditions employed. The loss in sensitivity to mitogenic stimuli after 7 days PB pre-treatment correlates with a reported decrease in receptor protein and mRNA levels in rats and coincides with the in vivo shift from hyperplasia to hypertrophy. More... »

PAGES

422-428

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002040050406

DOI

http://dx.doi.org/10.1007/s002040050406

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018383259

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9209687


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Separation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Replication", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epidermal Growth Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Growth Substances", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatocyte Growth Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperplasia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenobarbital", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB", 
          "id": "http://www.grid.ac/institutes/grid.6572.6", 
          "name": [
            "School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fletcher", 
        "givenName": "Karin", 
        "id": "sg:person.0701626175.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701626175.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Safety of Medicines Department, Zeneca Pharmaceuticals, Alderley Park, Macclesfield , SK10 4TG, UK, GB", 
          "id": "http://www.grid.ac/institutes/grid.417815.e", 
          "name": [
            "Safety of Medicines Department, Zeneca Pharmaceuticals, Alderley Park, Macclesfield , SK10 4TG, UK, GB"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Orton", 
        "givenName": "Terry C.", 
        "id": "sg:person.01005713060.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005713060.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB", 
          "id": "http://www.grid.ac/institutes/grid.6572.6", 
          "name": [
            "School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chipman", 
        "givenName": "J. Kevin", 
        "id": "sg:person.01072542354.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072542354.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB", 
          "id": "http://www.grid.ac/institutes/grid.6572.6", 
          "name": [
            "School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strain", 
        "givenName": "Alastair J.", 
        "id": "sg:person.0631732143.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631732143.23"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1997-05", 
    "datePublishedReg": "1997-05-01", 
    "description": "Abstract The ability was investigated of epidermal growth factor (EGF) and hepatocyte growth factor (HGF) to stimulate DNA synthesis in hepatocytes isolated from C57Bl/6J mice following 1, 3, 7, 30 and 90 days pre-treatment with the hepatomegalic drug, phenobarbitone (PB). A 3-fold increase in S-phase labelled hepatocytes was observed in the absence of growth factors after 3 days treatment with PB, which was not seen at other investigated time points. This suggests that the proliferative influence present in vivo at this time interval is maintained in the ex vivo model. Maximum labelling indices of >5-fold the unstimulated control value were observed in hepatocytes isolated from control and 1 day PB pre-treated mice when cultured in the presence of 5 or 10\u2009ng/ml EGF or HGF. Hepatocytes isolated from 3, 7, 30 or 90 day treated mice showed a considerably reduced responsiveness to growth factors; maximum labelling indices did not exceed by a factor of 2 the value obtained in the absence of growth factors. However, the apparent decrease in responsiveness to growth factors in hepatocytes isolated from 3 day pre-treated mice was due to an increased background level of proliferation and the attainment of a `ceiling level' of DNA synthesis at approx. 35%. DNA synthesis was not further enhanced by addition of both EGF and HGF. This maximal level of stimulation may indicate that only a specific hepatocyte sub-population is capable of responding to growth factors under the conditions employed. The loss in sensitivity to mitogenic stimuli after 7 days PB pre-treatment correlates with a reported decrease in receptor protein and mRNA levels in rats and coincides with the in vivo shift from hyperplasia to hypertrophy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002040050406", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1019669", 
        "issn": [
          "0340-5761", 
          "1432-0738"
        ], 
        "name": "Archives of Toxicology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "71"
      }
    ], 
    "keywords": [
      "pre-treated mice", 
      "hepatocyte growth factor", 
      "epidermal growth factor", 
      "maximum labeling index", 
      "growth factor", 
      "labeling index", 
      "unstimulated control value", 
      "ex vivo model", 
      "DNA synthesis", 
      "vivo shift", 
      "C57BL/6J mice", 
      "response of hepatocytes", 
      "days treatment", 
      "vivo model", 
      "control values", 
      "mice", 
      "proliferative influence", 
      "time points", 
      "phenobarbitone", 
      "mRNA levels", 
      "specific hepatocytes", 
      "maximal levels", 
      "hepatocytes", 
      "receptor protein", 
      "responsiveness", 
      "days", 
      "apparent decrease", 
      "factors", 
      "levels", 
      "hyperplasia", 
      "hypertrophy", 
      "rats", 
      "stimulation", 
      "time interval", 
      "drugs", 
      "index", 
      "absence", 
      "decrease", 
      "treatment", 
      "proliferation", 
      "vivo", 
      "ceiling level", 
      "correlates", 
      "stimuli", 
      "response", 
      "intervals", 
      "background levels", 
      "control", 
      "increase", 
      "sensitivity", 
      "protein", 
      "loss", 
      "presence", 
      "ability", 
      "increased background level", 
      "addition", 
      "values", 
      "attainment", 
      "synthesis", 
      "approx", 
      "Abstract", 
      "conditions", 
      "influence", 
      "point", 
      "model", 
      "phase", 
      "shift", 
      "coincide", 
      "hepatomegalic drug", 
      "day PB pre-treated mice", 
      "PB pre-treated mice", 
      "day pre-treated mice", 
      "days PB pre-treatment correlates", 
      "PB pre-treatment correlates", 
      "pre-treatment correlates"
    ], 
    "name": "The response of hepatocytes isolated from phenobarbitone treated mice to mitogenic growth factors", 
    "pagination": "422-428", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018383259"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002040050406"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9209687"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002040050406", 
      "https://app.dimensions.ai/details/publication/pub.1018383259"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_293.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002040050406"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002040050406'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002040050406'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002040050406'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002040050406'


 

This table displays all metadata directly associated to this object as RDF triples.

225 TRIPLES      21 PREDICATES      118 URIs      110 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002040050406 schema:about N0970bdf768604b70a5da7745bd8411a3
2 N19e464f448b547fbb683d8978c5a97b6
3 N3a4600f60330444bb817dac4217a9d91
4 N46122a4201ea4e3a980770b46814e838
5 N4f3bdf88cf48483095be0e9aa576feba
6 N59983cdfebc049fb90468f8ad62035e8
7 N5dee5931c61d4200a48a2f06b61197a9
8 N7472c1c428f54bd498bf9dcce5d1e220
9 N7dfd8821e1fc4836917daad545cd05a2
10 N86805125698d436a92de7e5af791c108
11 N8a789854a2184423afa2e78b6a429a60
12 N9cdc31ec1ea843e5bf2bc71e711ee198
13 Na0b43ea48f86472caf5b097cf39e653d
14 Na5144efb6e0d49ddb5d2a3e0bcd42df4
15 Na8f507f9ad9941c4986ab3d3862299e3
16 Nb52235d1fd134e258726163c8da3a644
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N36a3a05a4d8148689f3fa7590186111a
20 schema:datePublished 1997-05
21 schema:datePublishedReg 1997-05-01
22 schema:description Abstract The ability was investigated of epidermal growth factor (EGF) and hepatocyte growth factor (HGF) to stimulate DNA synthesis in hepatocytes isolated from C57Bl/6J mice following 1, 3, 7, 30 and 90 days pre-treatment with the hepatomegalic drug, phenobarbitone (PB). A 3-fold increase in S-phase labelled hepatocytes was observed in the absence of growth factors after 3 days treatment with PB, which was not seen at other investigated time points. This suggests that the proliferative influence present in vivo at this time interval is maintained in the ex vivo model. Maximum labelling indices of >5-fold the unstimulated control value were observed in hepatocytes isolated from control and 1 day PB pre-treated mice when cultured in the presence of 5 or 10‚ÄČng/ml EGF or HGF. Hepatocytes isolated from 3, 7, 30 or 90 day treated mice showed a considerably reduced responsiveness to growth factors; maximum labelling indices did not exceed by a factor of 2 the value obtained in the absence of growth factors. However, the apparent decrease in responsiveness to growth factors in hepatocytes isolated from 3 day pre-treated mice was due to an increased background level of proliferation and the attainment of a `ceiling level' of DNA synthesis at approx. 35%. DNA synthesis was not further enhanced by addition of both EGF and HGF. This maximal level of stimulation may indicate that only a specific hepatocyte sub-population is capable of responding to growth factors under the conditions employed. The loss in sensitivity to mitogenic stimuli after 7 days PB pre-treatment correlates with a reported decrease in receptor protein and mRNA levels in rats and coincides with the in vivo shift from hyperplasia to hypertrophy.
23 schema:genre article
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf N6dd5923627d3414eb642afec57993381
27 Nd2ca2634871d442984cd9bc4544628d1
28 sg:journal.1019669
29 schema:keywords Abstract
30 C57BL/6J mice
31 DNA synthesis
32 PB pre-treated mice
33 PB pre-treatment correlates
34 ability
35 absence
36 addition
37 apparent decrease
38 approx
39 attainment
40 background levels
41 ceiling level
42 coincide
43 conditions
44 control
45 control values
46 correlates
47 day PB pre-treated mice
48 day pre-treated mice
49 days
50 days PB pre-treatment correlates
51 days treatment
52 decrease
53 drugs
54 epidermal growth factor
55 ex vivo model
56 factors
57 growth factor
58 hepatocyte growth factor
59 hepatocytes
60 hepatomegalic drug
61 hyperplasia
62 hypertrophy
63 increase
64 increased background level
65 index
66 influence
67 intervals
68 labeling index
69 levels
70 loss
71 mRNA levels
72 maximal levels
73 maximum labeling index
74 mice
75 model
76 phase
77 phenobarbitone
78 point
79 pre-treated mice
80 pre-treatment correlates
81 presence
82 proliferation
83 proliferative influence
84 protein
85 rats
86 receptor protein
87 response
88 response of hepatocytes
89 responsiveness
90 sensitivity
91 shift
92 specific hepatocytes
93 stimulation
94 stimuli
95 synthesis
96 time interval
97 time points
98 treatment
99 unstimulated control value
100 values
101 vivo
102 vivo model
103 vivo shift
104 schema:name The response of hepatocytes isolated from phenobarbitone treated mice to mitogenic growth factors
105 schema:pagination 422-428
106 schema:productId N1c7bee13c4af474295a8f8b279e7bb6e
107 N2d83770bee0d4b38820c8b17ac0dbd44
108 N72f95aa2564e44bfbb9e3334e2f490bc
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018383259
110 https://doi.org/10.1007/s002040050406
111 schema:sdDatePublished 2021-11-01T18:02
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N5e58ead09be24c4faccd7523b33a0adc
114 schema:url https://doi.org/10.1007/s002040050406
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0970bdf768604b70a5da7745bd8411a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Epidermal Growth Factor
120 rdf:type schema:DefinedTerm
121 N19e464f448b547fbb683d8978c5a97b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Time Factors
123 rdf:type schema:DefinedTerm
124 N1c7bee13c4af474295a8f8b279e7bb6e schema:name doi
125 schema:value 10.1007/s002040050406
126 rdf:type schema:PropertyValue
127 N2d83770bee0d4b38820c8b17ac0dbd44 schema:name dimensions_id
128 schema:value pub.1018383259
129 rdf:type schema:PropertyValue
130 N36a3a05a4d8148689f3fa7590186111a rdf:first sg:person.0701626175.51
131 rdf:rest Nfbe51a7043ac414e8c07bb40fffa529c
132 N3a4600f60330444bb817dac4217a9d91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Animals
134 rdf:type schema:DefinedTerm
135 N40cdcf612c0746c4a626d3db6428397b rdf:first sg:person.01072542354.75
136 rdf:rest Ncd511b778f904fd38ea8d8fb31c696cd
137 N46122a4201ea4e3a980770b46814e838 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Hyperplasia
139 rdf:type schema:DefinedTerm
140 N4f3bdf88cf48483095be0e9aa576feba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Mice, Inbred C57BL
142 rdf:type schema:DefinedTerm
143 N59983cdfebc049fb90468f8ad62035e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Cell Separation
145 rdf:type schema:DefinedTerm
146 N5dee5931c61d4200a48a2f06b61197a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Hepatocyte Growth Factor
148 rdf:type schema:DefinedTerm
149 N5e58ead09be24c4faccd7523b33a0adc schema:name Springer Nature - SN SciGraph project
150 rdf:type schema:Organization
151 N6dd5923627d3414eb642afec57993381 schema:issueNumber 7
152 rdf:type schema:PublicationIssue
153 N72f95aa2564e44bfbb9e3334e2f490bc schema:name pubmed_id
154 schema:value 9209687
155 rdf:type schema:PropertyValue
156 N7472c1c428f54bd498bf9dcce5d1e220 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Growth Substances
158 rdf:type schema:DefinedTerm
159 N7dfd8821e1fc4836917daad545cd05a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Drug Synergism
161 rdf:type schema:DefinedTerm
162 N86805125698d436a92de7e5af791c108 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Liver
164 rdf:type schema:DefinedTerm
165 N8a789854a2184423afa2e78b6a429a60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Cell Division
167 rdf:type schema:DefinedTerm
168 N9cdc31ec1ea843e5bf2bc71e711ee198 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Mice
170 rdf:type schema:DefinedTerm
171 Na0b43ea48f86472caf5b097cf39e653d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Cells, Cultured
173 rdf:type schema:DefinedTerm
174 Na5144efb6e0d49ddb5d2a3e0bcd42df4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name DNA Replication
176 rdf:type schema:DefinedTerm
177 Na8f507f9ad9941c4986ab3d3862299e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Phenobarbital
179 rdf:type schema:DefinedTerm
180 Nb52235d1fd134e258726163c8da3a644 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Male
182 rdf:type schema:DefinedTerm
183 Ncd511b778f904fd38ea8d8fb31c696cd rdf:first sg:person.0631732143.23
184 rdf:rest rdf:nil
185 Nd2ca2634871d442984cd9bc4544628d1 schema:volumeNumber 71
186 rdf:type schema:PublicationVolume
187 Nfbe51a7043ac414e8c07bb40fffa529c rdf:first sg:person.01005713060.27
188 rdf:rest N40cdcf612c0746c4a626d3db6428397b
189 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
190 schema:name Medical and Health Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
193 schema:name Clinical Sciences
194 rdf:type schema:DefinedTerm
195 sg:journal.1019669 schema:issn 0340-5761
196 1432-0738
197 schema:name Archives of Toxicology
198 schema:publisher Springer Nature
199 rdf:type schema:Periodical
200 sg:person.01005713060.27 schema:affiliation grid-institutes:grid.417815.e
201 schema:familyName Orton
202 schema:givenName Terry C.
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005713060.27
204 rdf:type schema:Person
205 sg:person.01072542354.75 schema:affiliation grid-institutes:grid.6572.6
206 schema:familyName Chipman
207 schema:givenName J. Kevin
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072542354.75
209 rdf:type schema:Person
210 sg:person.0631732143.23 schema:affiliation grid-institutes:grid.6572.6
211 schema:familyName Strain
212 schema:givenName Alastair J.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631732143.23
214 rdf:type schema:Person
215 sg:person.0701626175.51 schema:affiliation grid-institutes:grid.6572.6
216 schema:familyName Fletcher
217 schema:givenName Karin
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701626175.51
219 rdf:type schema:Person
220 grid-institutes:grid.417815.e schema:alternateName Safety of Medicines Department, Zeneca Pharmaceuticals, Alderley Park, Macclesfield , SK10 4TG, UK, GB
221 schema:name Safety of Medicines Department, Zeneca Pharmaceuticals, Alderley Park, Macclesfield , SK10 4TG, UK, GB
222 rdf:type schema:Organization
223 grid-institutes:grid.6572.6 schema:alternateName School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB
224 schema:name School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK, GB
225 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...